@article{111176,
  author = {Lingtao Jin and Jaemoo Chun and Chaoyun Pan and Avi Kumar and Guojing Zhang and Youna Ha and Dan Li and Gina Alesi and Yibin Kang and Lu Zhou and Wen-Mei Yu and Kelly Magliocca and Fadlo Khuri and Cheng-Kui Qu and Christian Metallo and Taofeek Owonikoko and Sumin Kang},
  title = {The PLAG1-GDH1 Axis Promotes Anoikis Resistance and Tumor Metastasis through CamKK2-AMPK Signaling in LKB1-Deficient Lung Cancer},
  abstract = {<p>Loss of LKB1 is associated with increased metastasis and poor prognosis in lung cancer, but the development of targeted agents is in its infancy. Here we report that a glutaminolytic enzyme, glutamate dehydrogenase 1 (GDH1), upregulated upon detachment via pleomorphic adenoma gene 1 (PLAG1), provides anti-anoikis and pro-metastatic signals in LKB1-deficient lung cancer. Mechanistically, the GDH1 product α-KG activates CamKK2 by enhancing its substrate AMPK binding, which contributes to energy production that confers anoikis resistance. The effect of GDH1 on AMPK is evident in\&nbsp;LKB1-deficient lung cancer, where AMPK activation predominantly depends on CamKK2. Targeting GDH1 with R162 attenuated tumor metastasis in patient-derived xenograft model and correlation studies in lung cancer patients further validated the clinical relevance of our finding. Our study provides insight into the molecular mechanism by which GDH1-mediated metabolic reprogramming of glutaminolysis mediates lung cancer metastasis and offers a therapeutic strategy for patients with LKB1-deficient lung cancer.</p>
},
  year = {2018},
  journal = {Mol Cell},
  volume = {69},
  pages = {87-99.e7},
  month = {01/2018},
  issn = {1097-4164},
  url = {https://www.ncbi.nlm.nih.gov/pubmed/29249655},
  doi = {10.1016/j.molcel.2017.11.025},
  language = {eng},
}